Production (Stage)
Apellis Pharmaceuticals, Inc.
APLS
$17.44
-$0.34-1.91%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.63% | 17.04% | -13.28% | -41.18% | -56.91% |
| Total Receivables | -10.27% | 21.04% | 51.86% | 140.73% | 379.36% |
| Inventory | -46.42% | -49.29% | 12.18% | 51.77% | 88.02% |
| Prepaid Expenses | -3.44% | 10.65% | -29.04% | -0.19% | 34.31% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -19.58% | -39.50% | -51.29% | -54.48% | -22.63% |
| Total Current Assets | -10.32% | 2.95% | 4.66% | -3.66% | -14.97% |
|
|
|||||
| Total Current Assets | -10.32% | 2.95% | 4.66% | -3.66% | -14.97% |
| Net Property, Plant & Equipment | -7.42% | -9.74% | 0.81% | -8.65% | -19.45% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4,606.93% | 5,787.09% | 3,945.11% | 2,844.50% | 65.57% |
| Total Assets | -2.96% | 12.21% | 10.22% | -1.21% | -15.01% |
|
|
|||||
| Total Accounts Payable | 106.39% | 2.81% | 134.88% | 39.16% | -14.94% |
| Total Accrued Expenses | 14.54% | 9.68% | 19.43% | 25.65% | 42.31% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.98% | 4.84% | 18.35% | 6.19% | 7.36% |
| Total Finance Division Other Current Liabilities | -- | -- | -95.73% | -95.65% | 168.85% |
| Total Other Current Liabilities | -- | -- | -95.73% | -95.65% | 168.85% |
| Total Current Liabilities | -17.15% | -25.08% | 3.03% | -3.24% | 55.28% |
|
|
|||||
| Total Current Liabilities | -17.15% | -25.08% | 3.03% | -3.24% | 55.28% |
| Long-Term Debt | 386.98% | 386.74% | 386.51% | 392.24% | 0.32% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -5.98% | -10.94% | 4.88% | -8.13% | -26.17% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -99.16% | -96.71% | -96.68% | -99.07% | -23.28% |
| Total Liabilities | 13.77% | 10.49% | 13.45% | 12.27% | -0.26% |
|
|
|||||
| Common Stock & APIC | 3.80% | 7.63% | 8.62% | 8.61% | 9.47% |
| Retained Earnings | -7.70% | -6.97% | -9.10% | -12.76% | -16.78% |
| Treasury Stock & Other | 13.36% | 6.61% | -194.84% | -322.36% | -354.84% |
| Total Common Equity | -38.42% | 17.49% | 2.09% | -23.47% | -35.29% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -38.42% | 17.49% | 2.09% | -23.47% | -35.29% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -38.42% | 17.49% | 2.09% | -23.47% | -35.29% |
|
|
|||||